Understanding how women in midlife respond to physical activity measurement.
Predictors of Reactivity to Physical Activity Measurement among Women in Midlife with Elevated CVD Risk: Examination Across 7 Studies
This study looks at how women between 40 and 60 years old, who are at higher risk for heart disease, change their exercise habits when they know they're being watched, to help figure out what stops them from being more active and to find better ways to encourage them to move more.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rowan University NIH-funded |
| Lab location | 1 site (Glassboro, United States) |
| Project ID | NIH-10671010 on NIH RePORTER |
What this research studies
This research investigates how women aged 40-60 with elevated cardiovascular disease (CVD) risk change their physical activity levels when they know they are being measured. By analyzing data from seven different studies, the research aims to identify factors that influence these changes in behavior. The goal is to better understand the barriers that prevent women in midlife from engaging in physical activity, which is crucial for reducing their CVD risk. The findings could help improve methods for promoting physical activity in this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 40-60 who are at elevated risk for cardiovascular disease.
Not a fit: Patients outside the age range of 40-60 or those without elevated cardiovascular disease risk may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for encouraging physical activity among midlife women, ultimately reducing their risk of cardiovascular disease.
How similar studies have performed: While some preliminary evidence exists regarding physical activity measurement reactivity, this research aims to address gaps in understanding and is exploring a relatively novel approach.
Where this research is happening
Glassboro, United States
- Rowan University — Glassboro, United States (Active)
Researchers
- Principal investigator: Arigo, Danielle — Rowan University
- Study coordinator: Arigo, Danielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.